SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-21-022758
Filing Date
2021-01-29
Accepted
2021-01-29 16:51:45
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM F-3 d105279df3.htm F-3 364399
2 EX-5.1 d105279dex51.htm EX-5.1 21596
3 EX-23.1 d105279dex231.htm EX-23.1 4097
4 GRAPHIC g105279d0001_818392.jpg GRAPHIC 49429
5 GRAPHIC g105279dsp90.jpg GRAPHIC 3327
6 GRAPHIC g105279g02q20.jpg GRAPHIC 33289
7 GRAPHIC g105279g25e73.jpg GRAPHIC 3285
  Complete submission text file 0001193125-21-022758.txt   514757
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-252575 | Film No.: 21572001
SIC: 2834 Pharmaceutical Preparations